All News #Library
Biotech
Merck & Ridgeback Start Ph 3 Study of LAGEVRIO™ for COVID-19
05 Dec 2024 //
BUSINESSWIRE
Merck, Ridgeback withdraw COVID drug application in EU
27 Jun 2023 //
REUTERS

Market Place
Sourcing Support